RYTM

Rhythm Pharmaceuticals, Inc.

A biopharmaceutical company that makes medicines for rare genetic diseases of severe obesity, marked by insatiable hunger and excess weight gain. Its marketed drug, IMCIVREE (setmelanotide), is a precision medicine that restores a signaling pathway in the brain controlling hunger and fullness for patients with conditions such as Bardet-Biedl syndrome and POMC deficiency. Founded in 2008 in Boston, the company's name echoes the body's internal rhythm of hunger and metabolism its medicines aim to reset.

Recent Activity

Show $

2019Q4

1 sell

ArrowMark PartnersEXIT

-544.0K shares

ArrowMark PartnersEXIT

-544.0K shares

2019Q3

1 buy

ArrowMark PartnersADD

+7.8K shares(+1.5%)

ArrowMark PartnersADD

+7.8K shares(+1.5%)

2019Q2

1 sell

ArrowMark PartnersTRIM

-3.2K shares(-0.6%)

ArrowMark PartnersTRIM

-3.2K shares(-0.6%)

2019Q1

1 buy

ArrowMark PartnersADD

+24.5K shares(+4.8%)

ArrowMark PartnersADD

+24.5K shares(+4.8%)

Loading more activity...